The first thing our doctor noticed the day after his patient received the ACIST stem cells was her saying hello to him in a heartwarming fashion — completely different from the day before treatment when she was quiet and withdrawn. Post-op day one was a new beginning for this beloved mother and her daughter, fighting moms Alzheimers disease together.

When I brought the car to start driving her home, my mother got in and instead of being confused and trying to put the safety belt into the door as was typical, she put it in the buckle! excitedly explained her daughter during a call while driving home that same day.

Her mother had enrolled in MD Stem Cells new Alzheimers Autism Cognitive Impairment Stem Cell Treatment Study or ACISThis is the first open-label, non-randomized study designed for patients with dementias, including Alzheimers, treating them with their own bone marrow stem cells called BMSC. All enrolled patients receive active BMSC treatment- there is no placebo arm — making it different from most drug studies.